Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 10 | SFE2005 | Next issue

196th Meeting of the Society for Endocrinology and Society for Endocrinology joint Endocrinology and Diabetes Day

Special Interest Groups

Endocrinology of bone diseases: recent clinical and basic developments

ea0010s36 | Endocrinology of bone diseases: recent clinical and basic developments | SFE2005

Thyroid and bone

Williams G

Thyroid hormones are essential for skeletal development and bone maintenance. Childhood hypothyroidism causes growth arrest with delayed bone maturation, whereas thyrotoxicosis accelerates growth and advances bone age. In adults, thyrotoxicosis causes osteoporosis and increased susceptibility to fracture. To investigate mechanisms of T3 action in bone, we analyzed T3 receptor (TR) mutant mice. TRα-null (TRα0/0) mice are euthyroid but display delayed ossification with...

ea0010s37 | Endocrinology of bone diseases: recent clinical and basic developments | SFE2005

Understanding the molecular basis of adverse effects of bisphosphonate drugs in the treatment of bone diseases

Rogers M , Thompson K

Bisphosphonates are powerful inhibitors of bone resorption and have become blockbuster drugs in the treatment of metabolic bone diseases. Enormous progress has been made over the last few years in understanding exactly how bisphosphonate drugs act at the molecular level. After targeting bone and selective internalisation by osteoclasts, nitrogen-containing bisphosphonates potently inhibit FPP synthase. Inhibition of this enzyme disrupts the flux through the mevalonate pathway,...

ea0010s38 | Endocrinology of bone diseases: recent clinical and basic developments | SFE2005

Hormonal assays for calcitrophic hormones – PTH and FGF 23

Fraser W

Intact PTH [PTH(1–84)] measurements separate hypercalcaemic patients into 1) a parathyroid cause (usually 1°HPT) from 2) non-parathyroid causes (usually hypercalcaemia of malignancy). Improved sensitivity increases confidence in diagnosing hypoparathyroidism. PTH RIAs had problems with C-terminal PTH fragments and in renal failure circulating PTH (35–84) persists for hours giving high RIA PTH. Intact PTH is retained in renal failure and this resulted in new ap...

ea0010s39 | Endocrinology of bone diseases: recent clinical and basic developments | SFE2005

Vitamin D analogues: pharmacology and therapeutic uses

Bouillon R

Vitamin D is a substrate for the active hormone, 1α, 25-dihydroxyvitamin D3, which binds to a single vitamin D receptor (VDR) belonging to the class of nuclear transcription factors.Ligand activated VDR regulates about 3 % the mouse/human genome and has a wide variety of physiologic actions. Its regulates calcium and bone homeostasis by increasing transepithelial calcium transport (intestine, kidney) and regulates the functions of bone an...